NovoCure (NASDAQ:NVCR) Price Target Raised to $20.00
NovoCure (NASDAQ:NVCR – Free Report) had its target price boosted by Evercore ISI from $14.50 to $20.00 in a research report released on Tuesday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the medical equipment provider’s stock. A number of other brokerages have also recently weighed in on NVCR. Piper Sandler reaffirmed […]
More Stories
Weather, Power, and Water Issues Persist in Los Angeles’ Eaton Fire Area
By Beige Luciano-Adams LOS ANGELES—Residents eager to return home and survey vast damage wrought by the Eaton Canyon Fire in...
Titanium Transportation Group (CVE:TTR) Share Price Passes Below 50 Day Moving Average – Should You Sell?
Titanium Transportation Group Inc. (CVE:TTR – Get Free Report)’s share price passed below its 50 day moving average during trading...
Invesco Aerospace & Defense ETF (NYSEARCA:PPA) Stock Price Passes Below 50-Day Moving Average – Here’s Why
Invesco Aerospace & Defense ETF (NYSEARCA:PPA – Get Free Report) shares crossed below its fifty day moving average during trading...
ImmuPharma (LON:IMM) Shares Up 4.9% – What’s Next?
ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 4.9% during mid-day trading on Saturday . The company...
Omineca Mining and Metals (CVE:OMM) Stock Price Down 15.4% – Here’s Why
Omineca Mining and Metals Ltd. (CVE:OMM – Get Free Report)’s stock price traded down 15.4% on Saturday . The company...
China Shenhua Energy (OTCMKTS:CSUAY) Stock Passes Below 50 Day Moving Average – Here’s What Happened
Shares of China Shenhua Energy Company Limited (OTCMKTS:CSUAY – Get Free Report) passed below its 50 day moving average during...